Advances in Polatuzumab Vedotin-PIIQ Therapy: A Review of Treatment Efficacy in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

Polatuzumab vedotin (PV) is an antibody-drug conjugate that has shown promising results in the treatment of diffuse B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBCL). This abstract summarizes the current understanding of PV’s use in these malignancies based on available clinical data. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdur Raqib, Moosa, Haseeb, Abdul, Shafique, Muhammad Ashir, Fadlalla Ahmed, Tagwa Kalool, Mustafa, Muhammad Saqlain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589404/
https://www.ncbi.nlm.nih.gov/pubmed/37867604
http://dx.doi.org/10.2147/PHMT.S429252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589404/
https://www.ncbi.nlm.nih.gov/pubmed/37867604
http://dx.doi.org/10.2147/PHMT.S429252

Ejemplares similares